Introduction
Herpesvirus saimiri (saimiriine herpesvirus 2, HVS) is the T-lymphotropic prototype of the g2-herpesvirus family (Rhadinoviruses). 1 HVS is apathogenic in the natural host, the squirrel monkey (Saimiri sciureus), but causes acute T-cell lymphoma in other New World primates, such as tamarins (Sanguinus spp), owl monkeys (Aotus trivirgatus) or common marmosets (Callithrix jacchus). HVS strains can be divided into the subgroups A, B and C based on oncogenic potential and genomic sequence. [2] [3] [4] Subgroup C strains are able to transform human T cells, [5] [6] [7] whereby the genes stpC and tip are essential for transformation and induction of leukemia. 8 The genome of HVS C488 consists of a unique low G+C content L-DNA, which is flanked by multiple tandem repetitions containing high G+C, termed H-DNA. 9 The use of HVS as a vector for gene therapy was first documented in 1985 by infection of marmoset T cells and New World primates with recombinant bovine growth hormone-(bGH) producing recombinant virus. 10 The potential of HVS vectors for more general fields of application, besides T cells, was then recognized: the large packaging and cloning capacity, 11 the ability to infect and persist in many different cell types, including nondividing cells, and the long-term episomal persistence make HVS a promising gene therapy vector. 12, 13 Stable constitutive expression of marker genes has been shown in HVS, [14] [15] [16] [17] and the Tet-repressible system has been applied to investigate the transforming potential of the HTLV-1 tax gene with an HVS vector in human T-lymphocytes. 18 However, inducible expression of therapeutic transgenes has not been demonstrated with nontransforming HVS-based viral vectors. Various positively or negatively regulated eukaryotic expression systems are available; most are based on the selective modulation of a transactivator protein by a small amount of a specific inducer. This modulation turns the transgene expression on or off, respectively. Widely used are the steroid hormone-inducible and the tetracyclinecontrolled systems (Tet-on/off). 19 The Tet system has the additional advantage of well-studied pharmacodynamic properties of the inducer substances, which are tetracycline or doxycycline. The Dimerizer 20 and the Ecdysone 21 system are less widely used alternatives. A further inducible system is the antiprogestin system (GeneSwitcht, Invitrogen). 22 Current versions of this system consist of two components, the regulatory liganddependent transactivator protein and a specifically responsive promoter. The pSwitch plasmid encodes the regulatory GeneSwitcht fusion protein that is composed of the yeast GAL4-DNA-binding domain (GAL4DBD) fused to a truncated human Progesterone receptor ligand-binding domain (hPR-LBD), with a 19-aminoacid deletion at the C-terminal end, and the transactivating domain of the NF-kB p65 subunit at the C-terminus (p65-AD). The second component, the pGene plasmid, contains the gene of interest under the control of a hybrid promoter containing six copies of the GAL4-upstream activating sequence (GAL4-UAS). Only the inducer Mifepristone (or other Progesterone antagonists) 22 can selectively bind to the truncated hPR-LBD, and activate the system by changing the conformation of the GeneSwitcht-protein, which leads to dimerization, nuclear translocation and binding of the dimerized transactivator to the GAL4-UAS sequences within the hybrid promoters. This leads to the activation of transgene and transactivator protein expression. The GeneSwitcht-protein can also bind to four GAL4-UAS engineered to the hybrid HSV-TK promoter of the pSwitch plasmid and thus enhances its own expression.
We recently applied the system to study gammaherpesviral gene regulation and lytic replication of HVS by regulated expression of the viral LANA protein. 23 The well-known pharmacodynamic properties of Mifepristone and the documented functionality made the GeneSwitcht a notable option for inducible expression of potential therapeutic genes in HVS-based vectors. 22, [24] [25] [26] Heritable disease and cancer play a pivotal role in the large field of diseases that may be approached by curative or palliative gene therapy. However, inflammatory diseases like rheumatoid arthritis (RA) or osteoarthritis are also suitable targets for such a therapy. RA is a chronic inflammatory destructive joint disease with an incidence of about 1% of world population. 27 The pathogenesis of RA is characterized by an imbalance of pro-and anti-inflammatory cytokines, whereas the proinflammatory cytokines TNF-a and IL-1b represent the major players and maintain the state of inflammation. These cytokines also activate cartilage-degrading matrixmetalloproteinases (MMP), like MMP-1 (Collagenase-1) or MMP-3 (Stromelysin-1). In animal models, the constitutive expression of either IL-1 receptor antagonist (IL1-RA) or IL-10 was effective to counteract cartilage invasion or degradation, respectively, but results were more successful when both putative anti-inflammatory agents were combined. [28] [29] [30] In this study, a new generation of HVS vectors, including vectors that integrate the antiprogestin GeneSwitcht system in the viral context, were investigated for their ability to express the anti-inflammatory transgenes IL-1RA and IL-10 in human cells. Vector generation was performed by homologous recombination of overlapping cosmids, which is a well-studied method used for adeno-and herpesviruses. [31] [32] [33] The nontransforming HVS vectors allowed regulated or constitutive expression of these cytokines, and could interrupt IL-1b-stimulated expression of tissue-degrading factors by RA synovial fibroblast-like cells (RASF) in vitro.
Materials and methods

Cell culture and virus propagation
OMK cells (ATCC CRL1556) were used for the propagation of HVS. 34 The cells were cultivated in Dulbecco's modified Eagle's medium supplemented with glutamine (350 mg/ml), gentamycin (100 mg/ml) and 10% heatinactivated fetal calf serum (FCS, Biochrom KG, Berlin, Germany). Virus stocks were generated by infection of 70-90% confluent OMK cells in 175 cm 2 tissue culture flasks at a low multiplicity of infection (B0.1) (moi). When lysis was complete supernatants were stored at À801C. Titers of virus stocks, expressed as tissue culture infectious particles (TCIP)/ml, were determined by limiting dilution of virus stocks on OMK cells seeded in 96-well plates.
Human foreskin fibroblasts (HFF) and RASF (isolated as described elsewhere 35 ) were used for infection assays up to passage 18. The cells were cultivated in Dulbecco's modified Eagle's medium supplemented with glutamine (350 mg/ml), gentamycin (100 mg/ml), ciprofloxacin (10 mg/ml) and 10% heat-inactivated FCS (Biochrom KG, Berlin, Germany).
Cosmid vectors for Mifepristone-inducible or constitutive expression
In cosmid 331dBstZ1107IlacZ, the 1.8 kb Bst1107I fragment containing the tip and stpC oncogenes was substituted by a 0.4 kb PCR fragment comprising the multiple cloning site of pNEB193 (NEB GmbH, Frankfurt, Germany), including the a-fragment of b-galactosidase. In cosmid Dc5dBst1107IlacZ, the viral genes orf74 (viral homolog of IL-8R, G-protein-coupled receptor) and orf75 (the second viral homolog of formylglycineamide ribotide amidotransferase, FGARAT, E.C. 6.3.5.3), that are not essential for viral replication, were replaced by the same fragment. In these recipient cosmids, the afragment of b-galactosidase allowed color selection of recombinant cosmids by a-complementation. The expression cassette for the Mifepristone-dependent transcriptional activator protein (GeneSwitcht) was excised as a 3 kb BsrBI fragment from pSwitch and inserted into the single SwaI site of cosmid 331dBst1107IlacZ, at the noncoding region between the viral orf02 (dihydrofolatereductase, DHFR) and orf03 (viral homolog of FGARAT, E.C. 6.3.5.3), resulting in cosmid 331BLZ-Switch ( Figure  1 ). An inducible expression cassette for the IL-1RA gene was inserted into the PmeI site, within the lacZ region of 331BLZ-Switch as a 1.6 kb SspI-BsaAI fragment from the plasmid pGeneV5HisAdNotI-IL-1RA, to generate 331BLZ-Switch-IL-1RA (Figure 1 ). The second inducible transgene, IL-10, was inserted in an analogous way into the single PmeI site in cosmid Dc5dBst1107IlacZ, to generate Dc5BLZ-IL-10 ( Figure 1 ). The cosmids for the constitutive vector were constructed accordingly by insertion of CMV-promoter/enhancer expression cassettes for IL-1RA, IL-10 and IL-13 into the single PmeI site of the vector cosmids ( Figure 1 ). The cosmids 331dBst1107IcmvlacZ and Dc5 were used for the generation of the negative control vector HVS 331dBstcmvlacZ expressing b-galactosidase by the CMV-promoter/enhancer. This vector contains no constitutive or inducible interleukin-expressing cassette. The correct insertions into the cosmids were verified by 
Recombinant viruses
The recombinant viruses were constructed by liposomemediated cotransfection of five overlapping cosmids covering the complete, but stpC and tip deleted, HVS C488 genome into permissive OMK cells (Figure 1 ). 31 The cosmids were linearized by restriction enzyme digestion with NotI before transfection; this removed the pWE15 cloning vector, which contains two NotI sites flanking the single BamHI site that was used to clone the viral DNA. Preparation of viral DNA and virus verification by PCR About 1.5 ml of virus-containing OMK cell culture supernatants were cleared from cell debris by centrifugation at 1500 rpm for 10 min. Virus particles were collected from the cleared supernatants by centrifugation at 20 000 rpm for 90 min at 41C. The virus pellets were lysed in 100 ml PCR lysis buffer (50 mM KCl, 15 mM Tris, 2.5 mM MgCl 2 , 0.5% Tween-20, 100 mg Proteinase K) at 561C for 45 min. Proteinase K was heat inactivated at 951C for 15 min. A measure of 2 ml of these viral DNA solutions was added to PCR reactions. Strand synthesis was performed for 35 cycles (10 s 961C, 20 s 601C, 60 s 701C) in 50 ml total volume using 0.2 mM each primer, 0.2 mM each dNTP, 5 ml 10 Â AmpliTaq PCR buffer, 0.5 ml Taq polymerase (Figure 2c ). Long template PCR reactions were performed with the Expand High Fidelity PCR system (Roche Diagnostics, Germany) according to the manufacturer's protocol (Figure 2a) Preparation of viral DNA and virus verification by Southern blot analysis About 1.5 ml of virus-containing OMK cell culture supernatants were cleared from cell debris by centrifugation at 1500 rpm for 10 min. Virus particles were collected from the cleared supernatants by centrifugation The numbers in front and after each cosmid represent their position in the HVS genome. 7 In cosmid 331dBst1107IlacZ, the oncogenes stpC and tip were replaced by a fragment comprising the multiple cloning site of pNEB193 including the a-fragment of b-galactosidase. In cosmid Dc5dBst1107IlacZ orf75 (encodes for the viral FGARAT (E.C. 6.3.5.3)) and orf74 (encodes for the viral G-protein-coupled receptor (IL-8R), partially replaced) were replaced by the same fragment. Constitutive or inducible interleukin-containing expression cassettes were inserted into the PmeI site within this multiple cloning site. The BsrBI fragment from pSwitch containing the Mifepristone-dependent transcriptional activator protein (GeneSwitcht) was inserted into the SwaI site of cosmid 331dBst1107IlacZ, into the noncoding region between the viral orf02 (DHFR) and orf03 (viral homolog of FGARAT, E.C. 6.3.5.3), resulting in cosmid 331BLZ-Switch. An inducible expression cassette for the IL-1RA gene was inserted into the PmeI site, within the lacZ-polylinker region of 331BLZ-Switch as a 1.6 kb SspI-BsaAI fragment from the plasmid pGeneV5HisAdNotI-IL-1RA, to generate 331BLZ-Switch-IL-1RA. The second inducible transgene, IL-10, was inserted in an analogous way into the single PmeI site in cosmid Dc5dBst1107IlacZ, to generate Dc5BLZ-IL-10. Construction of the control vector was carried out by replacement of the Bst1107I-Bst1107I fragment by the CMV/IE-driven NruI-XmnI LacZ cassette. Plasmids pCDNA3NB-IL-1RA/10/13 and pCDNA3.1(À)dNo-)dNotlacZMycHis are obtained by insertion of the appropriate cassettes into plasmid pCDNA3 or pCDNA3.1. Plasmids pGeneV5HisAdNotI-IL-1RA/10 were constructed by modification of the pGene plasmid, which is a component of the GeneSwitcht-system. Regulated and constitutive expression of anti-inflammatory cytokines C Wieser et al at 20 000 rpm for 90 min at 41C. The virus pellets were lysed in 100 ml lysis buffer (1 Â TE (pH 8.5), 2% natrium-N-lauroylsarcosine, 200 mg/ml Proteinase K) at 561C for 60 min. Viral DNA was purified twice by phenolchloroform precipitation. The received DNA pellet was resuspended in H 2 O. Viral DNA (12 mg) was digested with SstI and the fragments were separated by gel electrophoresis on a 0.8% agarose gel. After depurination (0.25 N HCl, 20 min), denaturation (0.5 N NaOH/1.5 M NaCl, 30 min) and equilibration in transfer buffer (0.25 N NaOH/1.5 M NaCl), the DNA fragments were transferred to a Biodyne A membrane (Pall, England). The loaded membrane was air-dried and the DNA was fixed by baking for 30 min at 801C and UV crosslinking (0.5 J/ cm 2 ). After prehybridization (4 h, 371C), hybridization was performed with biotinylated probes (8 h, 371C), which represent fragments within the different overlap regions. For overlap region 3, two different probes were used (Figure 2b) . Preparation of biotinylated probes and detection were performed with the Phototope Kit (NEB GmbH, Germany) according to the manufacturer's protocol (Figure 2b ).
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Infection procedures and ELISA analysis
Cells were seeded in well plates or cell culture flasks (Nunc, Wiesbaden, Germany) and infected at a confluence of 70-90% with above-mentioned constitutive (Figure 3 ) or inducible HVS double cytokine vectors or negative control vector at a moi of 5, which means 5 TCIP/cell. All cell culture experiments were performed in duplicates. Cell number for moi was determined immediately before infection from a control well. At day 1 after infection, medium was changed completely and 2 ml 1 mM Mifepristone solution (in ethanol, Sigma, Munich, Germany) was added. Interleukin expression was detected from duplicate wells by IL-10 and IL-1RA ELISA (R&D Systems, Wiesbaden-Nordenstadt, Germany) according to the manufacturer's protocol. These infection procedures underlie all performed experiments. Deviations from the standard procedure are explained at the respective experiment. 
Time course of expression
RASF cells were grown in six-well plates (1.7 Â 10 5 cells/ well). Infection and induction was performed as described above (0.5 mM final Mifepristone concentration). After 1, 2, 3, 6, 9 and 14 days, samples of 1 ml were drawn and the withdrawn medium was replaced with fresh medium. Uninfected and control vector-infected cells served as negative controls. Interleukin expression was analyzed by ELISA ( Figure 6 ).
Real-time quantitative PCR
For detection of vector genomes, RASF and HFF cells were seeded in 75 cm 2 flasks (HFF: 7 Â 10 5 cells/flask; RASF: 5 Â 10 5 cells/flask) and infected and induced as described above. DNA was isolated 7 and 28 days post induction (Tissue Kit, Macherey-Nagel, Dü ren, Germany) and 250 ng/5 ml DNA per preparation was used for real-time PCR analysis of human CCR5 and viral MCP (orf25) in separate measurements. The PCR mixtures had a total volume of 50 ml and contained 0.2 mM 6-ROX (6-carboxy-X-rhodamine, Molecular Probes, Eugene, USA), PCR buffer (0.01% (v/v) gelatin, 0. Regulated and constitutive expression of anti-inflammatory cytokines C Wieser et al comparison to dilution series (10 À10 to 10 À1 copies) of standards processed in parallel (Table 1) . Each sample was analyzed in duplicate per measurement, and the total measurement was repeated once for each analysis.
Immunoblot analysis
For the detection of IL-1RA and IL-10 expression, HFF cells were seeded in 75 cm 2 flasks and infected with the above-mentioned constitutive double cytokine vectors. The medium was removed 1 day postinfection, and cells were washed with PBS and fresh medium was added. After 3 days, cell culture supernatant samples were drawn and 15 ml aliquots were separated by electrophoresis on 15% sodium dodecylsulfate-polyacrylamide gels (SDS-PAGE) and transferred to nitrocellulose membranes (Protran 
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Cytokine Array
The expression of 79 human cytokines was analyzed by a commercial sandwich-type assay (RayBiot Human Cytokine Array V, Raybiotech, Atlanta, GA, USA) that uses membrane-bound cytokine-specific antibodies to capture cytokines from biological fluids. RASF cells (donor no. 155, passage no. 8) were seeded out in six wells. After 1 day, the cells were transduced with a moi 5 of the inducible (HVS 5 0 Switch-IL-1RA-3 0 IL-10, two wells transduced) or the control vector (HVS 331dBstcmvlacZ, one well transduced). After 24 h, the medium was changed completely and the cells of one well, which have been transduced with the inducible vector, were induced with 2 ml 1 mM Mifepristone solution. The second well of inducible vector-transduced cells served as control. At 7 days after induction, supernatant samples (1.5 ml) were taken and incubated with the membranes of the Human Cytokine Array according to the manufacturer's instructions. The bound cytokines were then detected by incubation with respective cytokine-specific antibodies and horseradish peroxidase-coupled rabbit secondary antibody by ECL. The supernatant of analogous-treated uninfected RASF cells served as negative control.
Results
Construction and verification of recombinant HVS vectors
The nontransforming HVS vectors were generated by homologous recombination of five overlapping cosmids that cover the complete HVS genome (Figure 1 ). 31 Recombinant viruses can be obtained -without the possibility of wild-type virus contamination -after liposome-mediated transfection of the NotI-linearized cosmids into permissive OMK cells. All mentioned viruses and vectors were identical with respect to the backbone cosmids 261, 291 and 336, and showed growth and lytic replication comparable to wild-type virus. The vectors achieved equivalent high titers as measured by end-dilution titration calculated according to the Spearman-Kärber method. Insertion of the constitutive (CMVpromoter/enhancer) or inducible (GeneSwitcht) interleukin-containing cassettes was accomplished by modification of the left terminal cosmid 331dBst1107IlacZ and the right terminal cosmid Dc5dBst1107IlacZ (Figure 1 0 Switch-IL1RA-3 0 IL-10 with an moi of 5 as described above. The vector copy number per cell results from the relation of the virus copies to half the number of CCR5 copies (two copies per cell). All values are mean values of two independent measurements in duplicates. 0 Switch-IL1RA-3 0 IL-10 or the control vector HVS 331dBstcmvlacZ, each with a moi of 5. Cells were activated with 0.1 ng/ml IL-1b 3 days after Mifepristone induction in order to mimic the proinflammatory cytokineenriched environment of inflamed RA joints in vitro. Samples of cell culture supernatant were drawn 6 days postinduction and 50 ml aliquots of these supernatant samples were separated by SDS-PAGE. Interleukin expression in the inducible and constitutive vector system leads to reduced MMP-3 expression compared to uninfected, uninduced or control vectorinfected cells.
Regulated and constitutive expression of anti-inflammatory cytokines C Wieser et al constitutive vector carry both interleukins, IL-1RA and IL-10, whereas detection of the Mifepristone-dependent transcriptional activator protein cassette (GeneSwitcht) only was possible in the inducible vector system ( Figure  2c ). All vectors are positive for the viral orf03, but the recombinant types were stpC and tip deleted and therefore showed no PCR signal for these oncogenes, in contrast to the wild-type virus isolate. The function of the constitutive and inducible vector was also verified by Western blot and/or ELISA. Figure 3 (Figure 4a ). The specific inducer Mifepristone already activated the transgene expression at a concentration of 100 pM ( Figure  4b ), similar to observations in the original plasmid-based expression system. 22 In conclusion, the GeneSwitcht induction is sensitive and selective in the HVS genomic background.
Nontransforming HVS vectors are capable of longterm persistence in primary human fibroblasts
Persistent infection is a major characteristic of herpesviruses. In the case of HVS, earlier investigations have shown long-term persistence in various cell types. 12, 13 In order to investigate the respective behavior of the attenuated HVS vectors, we performed a real-time quantitative PCR, which allows the quantification of the viral DNA copies in relation to the total cell number. HFF and RASF cells were infected with the abovementioned constitutive double cytokine vector HVS 5 0 IL-1RA-3 0 IL-10 or inducible double cytokine vector HVS 5 0 Switch-IL-1RA-3 0 IL-10. At 1 day after infection, 2 ml of a 1 mM Mifepristone solution were added to the respective induced samples. Total DNA was isolated 7 and 28 days postinduction and real-time quantitative PCR was performed. Quantifications of the viral vector copies via orf25 (MCP) and of the total cell number via the CCR5 gene were carried out in separate measurements. In all samples of HFF and RASF cells, the number of virus copies per cell at day 28 was significantly lower than at day 7. In all cases, however, at least four copies per cell remained (Table 1) . Mean values of two independent measurements are shown.
HVS vector transgene expression in RASF cells is dependent on the moi
In order to determine the optimal amount of vector for maximal transgene expression and minimal side effects, RASF cells of different donors and passages were infected with variable amounts of the constitutive double cytokine vector HVS 5 0 IL-1RA-3 0 IL-10 or the inducible double cytokine vector HVS 5 0 Switch-IL-1RA-3 0 IL-10. At 1 day postinfection, 2 ml of a 1 mM Mifepristone solution were added to the respective induced samples. Supernatant samples were drawn 7 days postinfection and measured by IL-10 ELISA. In all three RASF donor samples, expression corresponded to the vector amount and was independent of the vector type ( Figure 5 ). When compared with the constitutive system, infection with the inducible system resulted in higher expression rates in all cases. Interestingly, earlier passages of RASF cells seemed to allow for higher expression rates. In summary, the inducible and the constitutive vector system were dependent on moi.
Time course of the transgene expression and comparison of the constitutive and inducible HVS vector systems RASF cells (donor no. 96, passage no. 12) were infected with the constitutive double cytokine vector HVS 5 0 IL-1RA-3 0 IL-10, the inducible double cytokine vector HVS 5 0 Switch-IL-1RA-3 0 IL-10 or the control vector HVS 331dBstcmvlacZ. After medium replacement, cells were selectively induced. Supernatant samples were drawn at different time points and analyzed for IL-10 expression. The uninduced, uninfected and control vectortreated cells showed no significant cellular or uninduced interleukin expression (Figure 6 ) above the lower limit of sensitivity of the ELISA assay, whereas the constitutive or inducible vector-infected cells expressed the recombinant interleukins up to 5 ng/ml. Corresponding to the former results ( Figure 5 ), the inducible vector system showed a higher transgene expression rate as the constitutive one. The onset of IL-10 expression from the inducible system was slightly delayed by 12-24 h when compared to the CMV-promoter/enhancerdriven constitutive vector system, which can be explained by the time-consuming activation step (data not shown). (Figure 7 ) compared to the uninfected or the control vector-treated samples. The constitutive vector seemed to be more efficient in blocking the IL-1b stimulated MMP-3 expression. In order to investigate the effects of the HVS vectors on the RASF cells, untransduced cells were compared to vector treated RASF in an Cytokine Array experiment that simultaneously detected secretion of 79 human cytokines ( Figure  8 ). Although the sensitivity of the assay is neither as high as ELISA assays, it is better considered as semiquantitative. Several human cytokines (IL-1b, TNF-a, IL-6 and IL-8) were also analyzed quantitatively by ELISA and did neither reveal significant differences (data not shown), similar to IL-6 expression in other experiments ( Figure 6 ). This shows that the general pattern of cytokine expression by the RASF target cells is not changed by vector treatment alone, but that a potentially relevant parameter, MMP-3, is repressed.
Discussion
HSV vectors have been investigated in several studies; 10, 14, 15, 17, 36, 37 they have an interesting and welldocumented potential with respect to cloning capacity, spectrum of transducable cell types and nonintegrating episomal persistence. Although regulated transgene expression might be beneficial in many gene therapeutic applications and different eukaryotic regulatory systems are available, conditionally expressed therapeutic genes had not been integrated in this vector type so far. Selectivity to the inducer, low background levels in the uninduced state and easy administration of the inducer substance, preferably free of side effects, are the requirements of a good regulated expression system; these points are accomplished by the plasmid based GeneSwitcht system. Thus, we decided to combine it with HVS vectors. The effects of vector modification and the influence of the viral context on the function of the regulated expression system are critical issues and had to be tested after the cloning procedures. First, verification of the obtained vectors was performed by restriction enzyme digestion (data not shown), PCR and Southern blot analysis (Figure 2 ). After this step, the functionality of the GeneSwitcht in the viral vector was investigated in HFF cells (Figure 3 ). Selective and sensitive induction by Mifepristone are basic requirements. Selectivity must be ensured at a concentration at which no crossreaction with other endogenous substances can occur in the organism wherein the vector finally will be administered. Figure 4a shows that no unselective activation occurs at a concentration of 1.5 mM Progesterone, which reflects more than 20 times of the maximal physiological serum concentration observed in women in the third trimenon (15-20 mg/l, equivalent to a concentration of about 0.07 mM). This corresponds to former investigations on the plasmid-based system, in which unphysiologically high Progesterone concentrations (up to 10 mM) also showed slight effects. 38 Considering this, unselective activation of the regulated expression system by endogenous Progesterone would be unlikely in humans. A difference in IL-10 and IL-1RA expression levels is evident from both Figure 4a and b. Possible explanations might be a different half-life of the two interleukins in cell culture and/or an IL-10-dependent activation of cellular IL-1RA synthesis. 39, 40 Since similar observations have been made in adenoviral vectors 30 and in our constitutive HVS vector system, it is unlikely to represent a property specific for the vector or the regulatory system. In case of such potent substances as interleukins, however, the observed differences should not play a major role and the expressed amounts should be sufficient to counteract inflammatory events.
Prevention of adverse reactions and ease of administration are additional requirements of the inducing substance. Mifepristone is a well-studied antiprogestin that in combination with prostaglandins is approved as an abortifacient in several countries. Therapeutic doses in women are usually in the range of 600 mg (single dose) or 10 mg/kg body weight and result in maximal plasma levels of 5.371.3 mM 1-2 h after oral administration. At these high doses, an induction of different MMPs has been shown in human cervical tissue. 41 Mifepristone might therefore be able to activate expression of MMPs in other cell types, which would counteract the effects of anti-inflammatory cytokines in the state of RA. However, this effect may also be tissue specific, and in contrast to cervical tissue, Mifepristone doses up to 1 mM had no effect on MMP synthesis in IL-1b-stimulated human chondrocytes. 42 Since glucocorticoids play a major role in RA therapy, the antiglucocorticoid effect of Mifepristone has to be mentioned. Such effects can occur at concentrations of 10-100 nM Mifepristone. 42 Their relevance for a combined glucocorticoid/viral vector therapy for RA remains be determined in future animal studies. In our study however, the inducible system can be activated at a concentration of 100 pM to nearly maximal expression (Figure 4b ), 100-fold less than the dose required for antiglucocorticoid effects. This also reflects a dose that is more than orders of magnitude lower than required for endogenous antagonistic effects, 43 and that corresponds to studies with the plasmid-based system. 22 A further aspect of inducible expression systems is the basal expression level. When several inducible expression systems were compared within an adenoviral context in three different cell lines by measuring luciferase activity, Xu et al 44 observed a slight basal expression of the uninduced antiprogestin expression system. In our study, significant basal or cellular expression of secreted IL-10 or IL1-RA cytokines was not detectable in primary human fibroblasts or RASF (Figure 6) , the values shown for IL-10 correspond to the lower limit of sensitivity of the IL-10 ELISA employed in the study. However, different behaviors of cell lines or other primary cells are conceivable; therefore, each cell type should be tested for each inducible system and viral context. The
Regulated and constitutive expression of anti-inflammatory cytokines C Wieser et al comparison of the two different vector types with respect to the time course of transgene expression shows that the inducible system achieves higher transgene protein expression, while the constitutive vector type might be beneficial when immediate transgene expression is desired (Figures 5 and 6 ). This phenomenon might be explained by the more time-consuming intermediate step of GeneSwitcht-protein expression, which is necessary before transgene production can be activated. So the choice of vector type depends on application area and required expression kinetics. Stable episomal viral persistence is characteristic of herpesvirus-based vectors and has been investigated for HVS in different cell types. 12, 13 In our case, real-time PCR was used to analyze viral persistence by measuring the viral DNA copies per target cell. This was done by comparing the DNA copy number of the gene for the viral major capsid protein (MCP, orf25) with the cellular ccr5 gene, which has no known pseudogenes and thus exists as a single copy per haploid human genome. Although some error may result from the observation that only 70-80% of such human mesenchymal cell populations are infectable, 14 the data demonstrate that several vector DNA copies per average target cell can persist for at least 28 days in primary human fibroblasts (Table 1) . A recent study has shown that, in the absence of selective pressure, HVS vectors Regulated and constitutive expression of anti-inflammatory cytokines C Wieser et al can persist with high efficiency of 92-96% per cell division in human cell lines. 45 RA is an inflammatory joint disease affecting about 1% of world population with a female:male ratio of 2.5:1. The pathophysiology of RA is characterized by hyperplasia of synovial linings and building of the pannus, which leads to cartilage degradation and joint erosions. The expression of MMPs, like MMP-1 (Collagenase-1) or MMP-3 (Stromelysin-1), is jointly responsible for this phenomenon; 27, 46 it is driven by proinflammatory cytokines, especially TNF-a and IL-1b. The treatment of RA has changed in the past years when new biological agents became available, like Infliximab and Etanercept, which both counteract the inflammatory effects of TNFa, and Anakinra, a recombinant IL-1RA; these drugs compensate or counteract the effects of the imbalance of pro-and anti-inflammatory cytokines in RA. These new therapeutic approaches with recombinant proteins are complicated by the frequently short half-life and the necessity for parenteral administration of the drug. Gene therapy can therefore still be considered as an alternative experimental approach for sustained drug delivery. 47 Specifically, the combination of IL-1RA and IL-10 has shown promising results since it inhibited cartilage invasion and degradation in an SCID mouse model of RA. 30 The blockade of the IL-1b-mediated MMP-3 expression in RASF cells by our double cytokine vectors ( Figure 7 ) indicates that such a gene therapy approach might be also possible with the HVS viral vector systems. In contrast to results in cervical tissue, 41 when we added nanomolar amounts of Mifepristone as inducing substance of the GeneSwitcht to transduced RASF cells, this resulted in a reduced MMP-3 expression; it did not counteract the reduction of MMP-3 expression and therefore confirms the general suitability of the inducible system for gene therapy of RA. From the same experiment, the secretion of IL-1b, TNF-a, IL-6 and IL-8 was analyzed by ELISA and did not reveal any significant differences (data not shown). Furthermore, a qualitative though less sensitive Cytokine Array experiment in RASF cells did neither reveal major differences in the secretion pattern of 79 human cytokines (Figure 8 ) in primary cells compared to vector-transduced cells, hinting at a rather inert behavior of the HVS vector.
In conclusion, this study demonstrates the successful integration of the antiprogestin-inducible expression system in combination with therapeutic genes in the context of an HVS vector. Transgene expression was selective and efficient, with very low background levels in primary human fibroblasts. The inducible expression system accomplished higher protein expression levels than the constitutive vector. In contrast, the constitutive vector leads to a faster onset of interleukin production than the inducible system, which requires the synthesis of the GeneSwitcht transactivator before inducible transgene expression can occur. Neither unselective induction within the relevant Mifepristone concentration range nor endogenous antagonistic effects by the inducing substance were observed. Episomal long-term persistence was shown by real-time PCR, and the function of the expressed therapeutic interleukins was shown blocking IL-1b-stimulated MMP-3 expression in RASF cells. This provides the basis for first preclinical trials of nontransforming constitutive and inducible HVS vectors.
